Buchumschlag

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial fibrillation (AF). We aimed to investigate whether the efficacy and safety of rivaroxaban compared with warfarin is consistent among the subgroups of pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hankey, Graeme (VerfasserIn) , Hacke, Werner (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 7, 2012
In: The lancet
Year: 2012, Jahrgang: 11, Heft: 4, Pages: 315-322
ISSN:1474-4465
DOI:10.1016/S1474-4422(12)70042-X
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/S1474-4422(12)70042-X
Verlag, Volltext: http://linkinghub.elsevier.com/retrieve/pii/S147444221270042X
Volltext
Verfasserangaben:Graeme J Hankey, Manesh R Patel, Susanna R Stevens, Richard C Becker, Günter Breithardt, Antonio Carolei, Hans-Christoph Diener, Geoffrey A Donnan, Jonathan L Halperin, Kenneth W Mahaffey, Jean-Louis Mas, Ayrton Massaro, Bo Norrving, Christopher C Nessel, John F Paolini, Risto O Roine, Daniel E Singer, Lawrence Wong, Robert M Califf, Keith AA Fox, Werner Hacke, for the ROCKET AF Steering Committee and Investigators
Beschreibung
Zusammenfassung:Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial fibrillation (AF). We aimed to investigate whether the efficacy and safety of rivaroxaban compared with warfarin is consistent among the subgroups of patients with and without previous stroke or transient ischaemic attack (TIA).
Beschreibung:Gesehen am 24.07.2018
Beschreibung:Online Resource
ISSN:1474-4465
DOI:10.1016/S1474-4422(12)70042-X

Ähnliche Einträge